Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.69B |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$1.36B |
| 3 |
Broadcom
AVGO
|
+$1.16B |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.07B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$2.99B |
| 2 |
Altria Group
MO
|
+$1.25B |
| 3 |
Carvana
CVNA
|
+$860M |
| 4 |
Danaher
DHR
|
+$829M |
| 5 |
RTX Corp
RTX
|
+$759M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Financials | 10.37% |
| 3 | Healthcare | 9.35% |
| 4 | Consumer Discretionary | 8.71% |
| 5 | Communication Services | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5051
Aura Biosciences
AURA
$826M
| $626K | ﹤0.01% |
82,840
-4,016
| -5% | -$29.4K |
|
5052
Freedom Holding
FRHC
$9.49B
| $624K | ﹤0.01% |
8,279
-1,035
| -11% | -$75.1K |
|
|
CRON
5053
Cronos Group
CRON
$1.14B
| $624K | ﹤0.01% |
267,804
-5,662
| -2% | -$14.6K |
|
5054
Fennec Pharmaceuticals
FENC
$402M
| $624K | ﹤0.01% |
102,085
+27,995
| +38% | +$232K |
|
5055
Verrica Pharmaceuticals
VRCA
$87.3M
| $619K | ﹤0.01% |
8,494
-4,928
| -37% | -$379K |
|
|
TEM
5056
Tempus AI
TEM
$9.39B
| $618K | ﹤0.01% |
+17,657
| New | +$541K |
|
5057
HF Foods Group
HFFG
$83.4M
| $618K | ﹤0.01% |
205,901
-1,893
| -0.9% | -$6.02K |
|
|
FAM
5058
DELISTED
First Trust/abrdn Global Opportunity Income Fund
FAM
| $615K | ﹤0.01% |
96,927
-5,560
| -5% | -$35.6K |
|
|
WRN
5059
Western Copper and Gold
WRN
$544M
| $614K | ﹤0.01% |
533,940
+527,200
| +7,822% | +$737K |
|
5060
Investcorp Credit Management BDC
ICMB
$12.1M
| $612K | ﹤0.01% |
182,101
+22,260
| +14% | +$72.3K |
|
5061
Invesco DB Precious Metals Fund
DBP
$255M
| $611K | ﹤0.01% |
10,656
| – | – |
|
5062
Amplify Online Retail ETF
IBUY
$112M
| $609K | ﹤0.01% |
11,054
+1,259
| +13% | +$69.5K |
|
5063
Codexis
CDXS
$158M
| $608K | ﹤0.01% |
196,124
-27,590
| -12% | -$88.6K |
|
5064
Cognyte Software
CGNT
$680M
| $602K | ﹤0.01% |
78,840
-93,368
| -54% | -$698K |
|
5065
Lightwave Logic
LWLG
$1.25B
| $602K | ﹤0.01% |
201,366
-21,429
| -10% | -$78.3K |
|
|
AZUL
5066
DELISTED
Azul
AZUL
| $602K | ﹤0.01% |
150,450
-1,321,150
| -90% | -$7.74M |
|
|
IPX
5067
IperionX
IPX
$909M
| $599K | ﹤0.01% |
43,000
-300
| -0.7% | -$4.29K |
|
5068
Tucows
TCX
$175M
| $598K | ﹤0.01% |
30,961
-24,227
| -44% | -$466K |
|
5069
Park-Ohio Holdings
PKOH
$756M
| $598K | ﹤0.01% |
23,099
-3,332
| -13% | -$84.7K |
|
5070
Century Casinos
CNTY
$34M
| $597K | ﹤0.01% |
215,702
-531,239
| -71% | -$1.54M |
|
5071
Taylor Devices
TAYD
$175M
| $597K | ﹤0.01% |
13,275
+1,029
| +8% | +$49.9K |
|
5072
Global X MSCI China Consumer Discretionary ETF
CHIQ
$127M
| $596K | ﹤0.01% |
35,750
-2,026
| -5% | -$36.6K |
|
5073
Lexicon Pharmaceuticals
LXRX
$1.1B
| $595K | ﹤0.01% |
354,036
+109,827
| +45% | +$197K |
|
5074
ProShares UltraPro S&P 500
UPRO
$5.7B
| $595K | ﹤0.01% |
7,739
-5,004
| -39% | -$347K |
|
5075
Acacia Research
ACTG
$470M
| $594K | ﹤0.01% |
118,537
-12,342
| -9% | -$63.9K |
|
Similar funds
Morgan Stanley's Q2 2024 Portfolio in Review
As of Q2 2024, Morgan Stanley held 8,106 positions worth $1.29T, up 3.7% from $1.25T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2024 filing shows 292 new, 3,358 increased, 3,239 reduced and 253 closed positions. Its largest new stake was iShares Bitcoin Trust: 5,500,627 shares worth $188M. The largest sale was Invesco QQQ Trust, an estimated $2.99B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
- Morgan Stanley's largest Q2 2024 buy was iShares Bitcoin Trust: 5,500,627 shares worth $188M.
- Morgan Stanley added most to Apple in Q2 2024, an estimated $1.69B increase.
- Morgan Stanley's biggest Q2 2024 reduction was Invesco QQQ Trust, cutting an estimated $2.99B.
- Morgan Stanley fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $664M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.29T portfolio in Q2 2024.
- Morgan Stanley opened 292 new positions and closed 253 in Q2 2024.
- Morgan Stanley's portfolio value rose 3.7% quarter-over-quarter to $1.29T.
Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.